These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31367157)

  • 1. Is the treatment outcome of hepatocellular carcinoma inferior in elderly patients?
    Chu KKW; Chok KSH
    World J Gastroenterol; 2019 Jul; 25(27):3563-3571. PubMed ID: 31367157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma in the elderly: Meta-analysis and systematic literature review.
    Hung AK; Guy J
    World J Gastroenterol; 2015 Nov; 21(42):12197-210. PubMed ID: 26576104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hepatocellular carcinoma: an overview of major findings from meta-analyses.
    Qi X; Zhao Y; Li H; Guo X; Han G
    Oncotarget; 2016 Jun; 7(23):34703-51. PubMed ID: 27167195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active treatments are a rational approach for hepatocellular carcinoma in elderly patients.
    Suda T; Nagashima A; Takahashi S; Kanefuji T; Kamimura K; Tamura Y; Takamura M; Igarashi M; Kawai H; Yamagiwa S; Nomoto M; Aoyagi Y
    World J Gastroenterol; 2013 Jun; 19(24):3831-40. PubMed ID: 23840122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
    Eggert T; Greten TF
    Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
    Peng Z; Chen S; Wei M; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Chen M; Qian G; Kuang M
    Radiology; 2018 May; 287(2):705-714. PubMed ID: 29390197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutics for advanced hepatocellular carcinoma: Recent advances, current dilemma, and future directions.
    Zhu J; Yin T; Xu Y; Lu XJ
    J Cell Physiol; 2019 Aug; 234(8):12122-12132. PubMed ID: 30644100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
    Han K; Kim JH
    World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Hepatocellular Carcinoma in Elderly Patients Focused on Management and Outcomes.
    Cho E; Cho HA; Jun CH; Kim HJ; Cho SB; Choi SK
    In Vivo; 2019; 33(5):1411-1420. PubMed ID: 31471386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment patterns and survival in patients with hepatocellular carcinoma in the Swedish national registry SweLiv.
    Henriksson M; Björnsson B; Sternby Eilard M; Lindell G; Strömberg C; Hemmingsson O; Isaksson B; Rizell M; Sandström P
    BJS Open; 2020 Feb; 4(1):109-117. PubMed ID: 32011814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria.
    Liu H; Wang ZG; Fu SY; Li AJ; Pan ZY; Zhou WP; Lau WY; Wu MC
    Br J Surg; 2016 Mar; 103(4):348-56. PubMed ID: 26780107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis.
    Wang JC; Xia AL; Xu Y; Lu XJ
    J Cell Physiol; 2019 Feb; 234(2):1062-1070. PubMed ID: 30256409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies.
    Chen BB; Shih IL; Wu CH; Hsu C; Chen CH; Shih TT; Liu KL; Liang PC
    J Vasc Interv Radiol; 2014 Mar; 25(3):371-8. PubMed ID: 24468045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage Hepatectomy for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation and/or Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis.
    Orimo T; Kamiyama T; Yokoo H; Wakayama K; Shimada S; Einama T; Kamachi H; Taketomi A
    Dig Surg; 2018; 35(5):427-434. PubMed ID: 28903105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone.
    Kim JH; Won HJ; Shin YM; Kim SH; Yoon HK; Sung KB; Kim PN
    Ann Surg Oncol; 2011 Jun; 18(6):1624-9. PubMed ID: 21445671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Survival in Hepatocellular Carcinoma Patients.
    Gokcan H; Savaş N; Oztuna D; Moray G; Boyvat F; Haberal M
    Ann Transplant; 2015 Oct; 20():596-603. PubMed ID: 26438974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience.
    Bettinger D; Spode R; Glaser N; Buettner N; Boettler T; Neumann-Haefelin C; Brunner TB; Gkika E; Maruschke L; Thimme R; Schultheiss M
    BMC Gastroenterol; 2017 Aug; 17(1):98. PubMed ID: 28797231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
    Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
    J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival].
    Díaz-Sánchez A; Matilla A; Núñez O; Merino B; Peligros I; Rincón D; Salcedo M; Lo Iacono O; Vega Catalina M; Clemente G; Bañares R
    Gastroenterol Hepatol; 2010 Mar; 33(3):155-64. PubMed ID: 19945770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.